About this trial
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.
Eligibility criteria
Qualifiers
Aged 50 years to 80 years
Currently smoke cigarettes or quit smoking cigarettes within the past 15 years
20 pack-year smoking history
Has never had lung cancer screening
Disqualifiers
Diagnosed with lung cancer
Has a history of having a lung cancer screening scan
Unable to speak and understand English
Trial design
Treatments tested in this trial
- LungTalk
- Non-tailored lung screening
Treatment groups
Sponsors and collaborators
Hackensack Meridian Health
Lead sponsor
New Jersey Commission on Cancer Research
Collaborator